A reliable companion for self-injection patients

Haselmeier_Re-Vario_Hor_v01.png

The Re-Vario™ technology platform is the basis for a compact, patient-centered solution for easy subcutaneous self-application. Designed based on extensive research and patient testing, the Re-Vario™ technology can help improve safety, convenience and quality of life. The Re-Vario™ technology platform features an attractive design and an extensive range of customization and different color examples.

The Re-Vario™ technology platform is the basis for a reusable dose injection device for diabetes treatment and other areas of care.

Easy handling and portability

Compact size that supports patient independence

A reliable companion

Anodized aluminium body to provide years of reliability

A versatile solution

Multiple injections and variable dosage
Haselmeier_Re-Vario_Hor_v01.png

Safe to use for patients

Easy dose correction to avoid injection errors and loss of drug

Clear and easy to read

Large and easy-to-read dose indicator

A reusable injection device

For use with a standard 3 ml cartridge

Datasheet - PDF

A closer look at the platform
Haselmeier_Re-Vario_Close_v01.png

Supporting an independent lifestyle

Many patients, such as those with diabetes, must follow lifelong treatment programs – and the Re-Vario™ technology platform is tailored to these needs. It's easy to handle, easy to transport and ready for safe and convenient use, and so helps patients to cope with their condition. Where subcutaneous self-injection is a regular routine, the Re-Vario™ technology can significantly improve quality of life.

Haselmeier_Re-Vario_Pack_v01.png

Packaging

Modern packaging for customized pens

We offer high end packaging design services that complement your products.

  • Areas of care

  • Areas of care

  • Areas of care

  • Areas of care

Diabetes GLP-1

Haselmeier offers pen solutions that support safe and efficient self-injection of GLP-1 – helping diabetes patients to manage their condition, and so aiding efforts to reduce costs and improve quality of care.

Diabetes Insulin

Haselmeier offers customizable injection pens and platform solutions that help type 1 and type 2 diabetes patients to self-administer insulin, promoting better compliance and more effective treatment.

Osteoporosis

We support convenience and compliance in osteoporosis treatment. The D-Flex™ can significantly improve therapy efficiency, allowing patients to treat themselves safely and discreetly on a long-term basis.

Oncology

Haselmeier's customizable pen solutions are suitable for use in some areas of oncology, supporting quality of care in this growing clinical domain. The solutions could improve patients' quality of life and create a basis for reliable and successful therapy at home.

Let's talk about your customized injection pen

As a full-service provider, Haselmeier solutions include more than R&D consulting, product engineering, and development services. We also provide certified pharmaceutical manufacturing services, and so are able to offer a comprehensive assembly, labeling and packaging services including intellectual property and technology licensing assistance.

Get In Touch